Medicare Enrolled

Dr. Allan Spiegel, MD

Neurology · Palm Harbor, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
31608 US 19 NORTH, Palm Harbor, FL 34684
7277877077
In practice since 2006 (19 years)
NPI: 1235148743 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Spiegel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Spiegel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Spiegel

Dr. Allan Spiegel is a neurology specialist in Palm Harbor, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Spiegel performed 6,060 Medicare services across 3,099 unique beneficiaries.

Between the years covered by Open Payments, Dr. Spiegel received a total of $20,435 from 65 pharmaceutical and/or device companies across 1030 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Spiegel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in FL $20,435 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 45063 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
6,060
Medicare services
Top 14% in FL for neurology
3,099
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~319 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,249 $92 $365
Physical therapy exercise, per 15 min
A therapy session using exercises to improve strength, endurance, range of motion, and flexibility. Each 15-minute unit is billed separately.
605 $17 $83
Speech and language therapy
Treatment for disorders affecting speech, language, voice, communication, and hearing processing.
507 $57 $214
Functional capacity test, per 15 minutes
A test or measurement to assess functional capacity. The service is billed for each 15-minute increment.
499 $25 $95
Neuromuscular re-education therapy, per 15 min
A therapy procedure designed to re-educate the functional connection between the brain, nerves, and muscles. It is billed in 15-minute increments.
390 $21 $96
Manual therapy (hands-on treatment), per 15 min 321 $16 $77
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
312 $120 $477
Functional activity therapy
A therapy procedure that utilizes functional activities as part of the treatment process.
288 $27 $106
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
240 $69 $268
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
238 $67 $260
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
182 $74 $281
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
129 $325 $1,264
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
117 $99 $370
Additional hour of neuropsychological test evaluation
This code covers the evaluation of neuropsychological testing for each additional hour beyond the initial service. It represents the time spent analyzing and interpreting test results.
115 $75 $286
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
93 $1 $25
Substance misuse assessment and brief intervention
A structured assessment of alcohol or substance misuse combined with a brief intervention lasting 15 to 30 minutes.
88 $26 $109
Psychological or neuropsychological test, first 30 minutes
Administration of psychological or neuropsychological testing for the first 30 minutes.
81 $31 $126
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
74 $133 $514
Speech and language evaluation
Assessment of how well a person produces speech sounds and their ability to understand and express language.
60 $164 $646
Walking/gait training therapy, per 15 min
A therapy session focused on training walking skills. The service is billed in 15-minute increments.
60 $17 $84
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
58 $11 $40
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
58 $1 $15
Evaluation for physical therapy, typically 20 minutes 49 $75 $283
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
44 $88 $323
Vestibular function test with thermal irrigation
A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function.
29 $31 $115
Balance testing with recording
A procedure to evaluate balance function by recording the results during testing.
29 $81 $306
Use of electrodes during balance testing
Application of electrodes to monitor physiological responses during a balance assessment.
29 $8 $28
Vestibular function test using rotating chair
This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability.
28 $92 $339
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
27 $158 $619
Balance and posture test
A test to evaluate a patient's balance and posture. This assessment measures stability and body alignment.
24 $35 $138
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $37 $161
New patient office visit, complex (60-74 min) 16 $164 $631
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,435
Total received (2018-2024)
Avg $2,919/year across 7 years
Top 15% in FL for neurology
65
Companies
1,030
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,525 (85.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,910 (14.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,473
2023
$3,416
2022
$2,803
2021
$2,736
2020
$2,265
2019
$1,550
2018
$4,193

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$3,368
UCB, Inc.
$2,184
Avanir Pharmaceuticals, Inc.
$831
AbbVie Inc.
$760
Lilly USA, LLC
$758
ACADIA Pharmaceuticals Inc
$717
Teva Pharmaceuticals USA, Inc.
$669
ABBVIE INC.
$639
ARGENX US, INC.
$608
Novartis Pharmaceuticals Corporation
$596
Amgen Inc.
$578
Takeda Pharmaceuticals U.S.A., Inc.
$564
Otsuka America Pharmaceutical, Inc.
$534
Eisai Inc.
$527
Neurocrine Biosciences, Inc.
$464
SK Life Science, Inc.
$463
PFIZER INC.
$454
UPSHER-SMITH LABORATORIES LLC
$419
Lundbeck LLC
$391
Biohaven Pharmaceuticals, Inc.
$320
MDD US Operations, LLC
$317
Celgene Corporation
$315
Allergan, Inc.
$278
Acorda Therapeutics, Inc
$262
GE HealthCare
$260
GE HEALTHCARE
$256
Sunovion Pharmaceuticals Inc.
$254
Amneal Pharmaceuticals LLC
$209
Upsher-Smith Laboratories LLC
$186
Avion Pharmaceuticals
$185
EISAI INC.
$175
CATALYST PHARMACEUTICALS, INC.
$170
Sumitomo Pharma America, Inc.
$157
SCILEX PHARMACEUTICALS INC.
$151
Neurelis, Inc.
$119
Biohaven Pharmaceutical Holding Company Ltd.
$119
JAZZ PHARMACEUTICALS INC.
$100
Biogen, Inc.
$96
Abbott Laboratories
$94
Corium, LLC
$93
IDORSIA PHARMACEUTICALS US INC
$81
EMD Serono, Inc.
$63
Allergan Inc.
$59
Catalyst Pharmaceuticals, Inc.
$57
ARBOR PHARMACEUTICALS, INC.
$56
Impax Laboratories, Inc.
$52
Nevro Corp.
$48
LivaNova USA, Inc.
$45
Collegium Pharmaceutical, Inc.
$34
Arbor Pharmaceuticals, Inc.
$29
Life Molecular Imaging Ltd
$28
Harmony Biosciences LLC
$26
AstraZeneca Pharmaceuticals LP
$24
Vertical Pharmaceuticals, LLC
$23
Bayer HealthCare Pharmaceuticals Inc.
$20
SI-BONE, INC.
$18
Janssen Pharmaceuticals, Inc
$17
PORTOLA PHARMACEUTICALS, INC.
$17
Horizon Therapeutics plc
$16
Adamas Pharmaceuticals, Inc.
$16
Merz Pharmaceuticals, LLC
$15
Promius Pharma LLC
$14
Currax Pharmaceuticals LLC
$13
GlaxoSmithKline, LLC.
$13
CSL Behring
$13
Top 3 companies account for 31.2% of total payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BEXSERO · BOTOX · BRILINTA · Betaseron · Briviact · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · DUEXIS · DUOPA · Dayvigo · Dhivy · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Ellipse ICD · FIRDAPSE · FYCOMPA · Fortify Assura · Fycompa · GAMMAGARD · GOCOVRI · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MOVANTIK · Mavenclad · NAMZARIC · NEURACEQ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OXTELLAR XR · Omnia · Ongentys · PAXLOVID · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RELEXXII · REXULTI · RYTARY · Rebif · Rystiggo · SUNOSI · Senza · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · UBRELVY · VALTOCO · VNS Therapy · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XCOPRI · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $337 per 100 Medicare services performed
Looking for a neurology specialist in Palm Harbor?
Compare neurologists in the Palm Harbor area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
175
Per 100K population
18.2
County median income
$70,293
Nearest hospital
MEASE DUNEDIN HOSPITAL
5.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Spiegel is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), with low-engagement industry engagement in the top 15% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Spiegel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Spiegel performed 1,249 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Spiegel receive payments from pharmaceutical companies?
Yes. Dr. Spiegel received a total of $20,435 from 65 companies across 1,030 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Spiegel's costs compare to other neurologists in Palm Harbor?
Dr. Spiegel's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Spiegel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →